Firms Vow To Appeal After CMA’s £260m Hydrocortisone Fines In UK
Accord, Advanz And Waymade Respond To Decision By Competition Regulator
Firms censured by the UK’s CMA competition regulator over illegal deals that drove up the price of hydrocortisone for around a decade have vowed to appeal against the decision and the imposition of fines totaling more than £260m.
